Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report

por Guan, Yun, Li, Jing, Gong, Xiu, Zhu, Huaguang, Li, Chao, Mei, Guanghai, Liu, Xiaoxia, Pan, Li, Dai, Jiazhong, Wang, Yang, Wang, Enmin, Liu, Ying, Wang, Xin
Publicado 2022

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience

por Guan, Yun, Xiong, Ji, Pan, Mingyuan, Shi, Wenyin, Li, Jing, Zhu, Huaguang, Gong, Xiu, Li, Chao, Mei, Guanghai, Liu, Xiaoxia, Pan, Li, Dai, Jiazhong, Wang, Yang, Wang, Enmin, Wang, Xin
Publicado 2021

A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma...

por Guan, Yun, Pan, Mingyuan, Yang, Jun, Lu, Qiuxia, Han, Liangfu, Liu, Ying, Li, Jing, Zhu, Huaguang, Gong, Xiu, Mei, Guanghai, Liu, Xiaoxia, Pan, Li, Dai, Jiazhong, Wang, Yang, Wang, Enmin, Wang, Xin
Publicado 2022